Will Mylan’s big Copaxone price break force Teva’s hand? Clients are pushing already

Thanks to Mylan’s gigantic price cut on generic Copaxone from earlier this month, Teva’s going to have to take the price on its branded product down. And it would be wise to start now, one analyst says.